← Eichor
Condition: Uterine Diseases Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Uterine Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Image-Guided Gynecologic Brachytherapy
NA · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT02993900
Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06413992
Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
Phase 2/Phase 3 · 1 location(s) · Xiaojun Chen · NCT05316493
a Single-arm, Single-center, Open Clinical Study
Phase N/A · 1 location(s) · Beijing Geekgene Technology Co., LTD · NCT06431100
HPV After chemoRadioTherapy
Phase N/A · 1 location(s) · General University Hospital, Prague · NCT07493928
Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoin
NA · 1 location(s) · Peking University People's Hospital · NCT07318727
HPV-based Screening Among Women 23-29 Years of Age
NA · 2 location(s) · Karolinska Institutet · NCT05229679
Pocket Colposcopy Using CARE Algorithm
NA · 1 location(s) · Duke University · NCT06458062
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemothera
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT04997096
Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04712851
Transvaginal Sacrospinous Hysteropexy Versus Laparoscopic Uterine Lateral Suspension
Phase N/A · 1 location(s) · National Cheng-Kung University Hospital · NCT05586984
Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery
Phase 2 · 1 location(s) · Xiaohua Wu · NCT06209294
Modified Tumor-free Techniques Operation to Cervical Cancer
NA · 17 location(s) · Peking Union Medical College Hospital · NCT06836869
Neoadjuvant Therapy in Cervical Cancer
NA · 1 location(s) · Qilu Hospital of Shandong University · NCT06558682
Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
Phase 2 · 1 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06640283
Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
Phase 2 · 2 location(s) · Tongji Hospital · NCT06289751
Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer
NA · 1 location(s) · Siriraj Hospital · NCT07595224
Induction Immunotherapy Combined With Chemotherapy Followed by Concurrent Chemoradiotherap and Immunotherapy for Cervica
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07092696
Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT07467772
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
NA · 1 location(s) · Jessica D. St. Laurent, MD · NCT07220239
Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endo
Phase 3 · 15 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT06712472
Transperineal Ultrasound Evaluation of Vesicourethral Angle and de Novo SUI After Colpocleisis Surgery
NA · 1 location(s) · Gaziosmanpasa Research and Education Hospital · NCT07071818
Multimedia Aid for Genetic Testing in Gynecologic Oncology
NA · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT07084168
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
Phase N/A · 1 location(s) · National Cancer Institute, Naples · NCT06893861
TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC
Phase 2 · 1 location(s) · Fudan University · NCT06914297
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unr
Phase 1 · 1 location(s) · Aaron Wolfson · NCT05603910
Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vagin
Phase N/A · 3 location(s) · University of Aarhus · NCT07400835
In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions
NA · 1 location(s) · University Hospital, Rouen · NCT03371641
Binaural Sound for Remimazolam Maintenance
NA · 1 location(s) · Gangnam Severance Hospital · NCT06497283
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
Phase N/A · 1 location(s) · University Hospital Tuebingen · NCT05914974
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.